The absence of selling and strong passive buying may provide short-term price support; however, traders should monitor for active manager participation to confirm a broader shift in sentiment. Given the small float and market cap, further index inclusion or rebalancing could trigger additional passive inflows.
Executive Summary
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and UBS — significantly increased their positions in Monte Rosa Therapeutics (GLUE) during Q4 2024, collectively adding $15.6 million in new holdings. All three institutions doubled their exposure, with Morgan Stanley accounting for the vast majority of the activity, increasing its stake by over 2 million shares. This coordinated accumulation suggests growing institutional interest in the stock despite its small market cap and lack of recent fundamental updates.
Key Financial Metrics
Institutional Positions
Net institutional flow: $15.6M
▲ Buyers (3)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Morgan Stanley | DOUBLED | +1699.5% | $15.7M | $15.0M |
| Wells Fargo | DOUBLED | +215.9% | $487.0K | $369.0K |
| UBS | DOUBLED | +134.5% | $412.0K | $278.0K |
Key Facts
- Morgan Stanley increased its GLUE position by 2.13 million shares, adding $15.0M in value.
- Wells Fargo and UBS added $369K and $278K respectively, more than doubling their holdings.
- No institutional selling was detected in this quarter, indicating one-sided institutional demand.
- All buyers are classified as mega-passive institutions, suggesting index-related or model-driven buying rather than activist or fundamental conviction.
Financial Impact
3 institutions accumulated $15.6M in new positions, increasing total institutional holdings to $16.6M.
Risk Factors
- Buying is driven entirely by passive institutions, which may not reflect fundamental conviction.
- Low float and high volatility make GLUE susceptible to sharp reversals if sentiment shifts.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-GLUE-2024-Q4 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 26d ago | 8-K | $11.26 | awaiting T+60 | — | — |
Sep 30, 2026 26d ago | Press Release | $11.26 | awaiting T+60 | — | — |
Aug 6, 2026 11w ago | 8-K | $15.71 | awaiting T+60 | — | — |
Jul 17, 2026 14w ago | Insider Cluster | $23.48 $9.89 | ▼ −57.88% | ▼ −62.72% | — |
Jul 7, 2026 15w ago | Insider Cluster | $24.06 $11.93 | ▼ −50.42% | ▼ −52.73% | — |
Jul 1, 2026 16w ago | Insider Cluster | $24.21 $11.72 | ▼ −51.59% | ▼ −54.60% | — |
Jul 1, 2026 16w ago | Insider Cluster | $24.21 $11.72 | ▼ −51.59% | ▼ −54.60% | — |
Jun 29, 2026 17w ago | 144 | $24.20 $11.89 | ▼ −50.87% | ▼ −54.43% | — |
Jun 25, 2026 17w ago | Insider Cluster | $22.29 $12.60 | ▼ −43.47% | ▼ −49.56% | — |
Jun 2, 2026 20w ago | Insider Cluster | $17.59 $14.32 | ▼ −18.59% | ▼ −21.09% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers